Parkinson's Disease
This track focuses on the latest advancements in understanding, diagnosing, and treating Parkinson's Disease (PD). Speakers will discuss breakthroughs in neuroimaging, molecular biomarkers, and novel therapeutic approaches, including gene therapy and deep brain stimulation. Delegates will gain firsthand knowledge of emerging treatments aimed at slowing disease progression and improving patient quality of life. Networking opportunities with experts in neurology, pharmacology, and rehabilitation offer a unique platform for collaboration. Attending this track equips participants with the latest clinical strategies and research insights to enhance patient care and therapeutic outcomes.

